SCHEMBL27725837

SCHEMBL27725837

[CH2]CCc1nc(N2CCN(c3ccccc3)CC2)nc2c1SCC2

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 7/20 0.44
▸ ALDH1A1 P00352 6/20 0.44
▸ KMT2A Q03164 2/20 0.44
▸ HSD17B10 Q99714 2/20 0.44
▸ MEN1 O00255 1/20 0.44
▸ TSHR P16473 5/20 0.43
▸ HPGD P15428 4/20 0.43
▸ HTT P42858 2/20 0.43
▸ SMN1; SMN2 Q16637 3/20 0.40
▸ LMNA P02545 2/20 0.39
▸ USP2 O75604 2/20 0.39
▸ GAA P10253 2/20 0.38
▸ PDE11A Q9HCR9 3/20 0.38
▸ PDE2A O00408 2/20 0.36
▸ NPSR1 Q6W5P4 1/20 0.36
▸ PDE4A P27815 1/20 0.36
▸ PDE6C P51160 1/20 0.36
▸ PDE10A Q9Y233 1/20 0.36
▸ PDE1B Q01064 1/20 0.36
▸ DCTPP1 Q9H773 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2919544 0.86 MAPT (0.42) MAPTALDH1A1KMT2AHSD17B10MEN1
SCHEMBL2916955 0.86 MAPT (0.45) MAPTALDH1A1KMT2AHSD17B10MEN1
SCHEMBL2918582 0.80 MAPT (0.49) MAPTALDH1A1KMT2AHSD17B10MEN1
SCHEMBL3026830 0.77 PDE11A (0.43) MAPTALDH1A1KMT2AHSD17B10MEN1
SCHEMBL2918449 0.76 HTR2C (0.47) MAPTALDH1A1KMT2AHSD17B10MEN1
SCHEMBL3948728 0.74 CETP (0.42) MAPTALDH1A1KMT2AHSD17B10MEN1
SCHEMBL2922400 0.74 MAPT (0.35) MAPTALDH1A1KMT2AHSD17B10MEN1
SCHEMBL2916952 0.74 PDE11A (0.42) MAPTALDH1A1KMT2AHSD17B10MEN1
SCHEMBL2920930 0.74 MAPT (0.37) MAPTALDH1A1KMT2AHSD17B10MEN1
SCHEMBL2923828 0.74 CETP (0.42) MAPTALDH1A1KMT2ATSHRSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101163706-A Dihydrothienopyrimidines for the treatment of inflammatory diseases BOEHRINGER INGELHEIM INT (DE) 2008-04-16 — — CN disclosed
Send feedback